EDSA Edesa Biotech, Inc.

NASDAQ
$2.14

Edesa Biotech, Inc. (EDSA) SEC Filings

Everything EDSA has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

63 filings
Date Form Filing
8-K Agreement Terminated · Material Agreement · Other Reg Fd · Reg Fd View filing
4 View filing
SCHEDULE 13G/A View filing
4 View filing
8-K Executive Change · Other View filing
8-K Other · Other Event View filing
4 View filing
4 View filing
SCHEDULE 13G View filing
SCHEDULE 13D/A View filing
SCHEDULE 13D/A View filing
8-K Capital Raise · Material Agreement · Other Event View filing
10-Q View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
10-Q View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
4 View filing
10-Q View filing
4 View filing
4 View filing
10-K View filing
4 View filing
4 View filing
4 View filing
4 View filing
10-Q View filing
10-Q View filing
10-Q View filing
10-K/A View filing
10-K View filing
10-Q View filing
10-Q View filing
10-Q View filing
10-K View filing
10-Q View filing
10-Q View filing
10-K/A View filing
10-Q View filing
10-K View filing
10-Q View filing
10-Q View filing
10-Q View filing
10-K View filing

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.